Concepedia

Grégori Gerebtzoff

GG

10

Publications

614

Citations

10

H-Index

2004

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Basel

Roche (Switzerland)

Grégori Gerebtzoff is an author at Novartis (Switzerland) specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug AnalysisToxicologyEngineeringBiostatisticsMachine LearningChemistryDiagnosis

Publications per year

2004–2024

10

Publications

10

Halogenation of Drugs Enhances Membrane Binding and Permeation

Grégori Gerebtzoff, Xiaochun Li‐Blatter, Holger Fischer et al. · ChemBioChem · 2004 · 279 citations

Pharmaceutical Science, Biochemistry, Medicine +12

In Silico Prediction of Blood−Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter

Grégori Gerebtzoff, Anna Seelig · Journal of Chemical Information and Modeling · 2006 · 78 citations

Safety screening in early drug discovery: An optimized assay panel

Stefanie Bendels, Caterina Bissantz, Bernhard Fasching et al. · Journal of Pharmacological and Toxicological Methods · 2019 · 78 citations

Drug Safety, Predictive Toxicology, Preclinical Drug Evaluation +10

Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties

Elena Di Lascio, Grégori Gerebtzoff, Raquel Rodríguez-Pérez · Molecular Pharmaceutics · 2023 · 37 citations

Application of machine learning models for property prediction to targeted protein degraders

Giulia Peteani, Minh Huynh, Grégori Gerebtzoff et al. · Nature Communications · 2024 · 36 citations · Full text

Rows per page

1–5 of 10